Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers

Molecular Cancer Therapeutics

Volumn 7, Issue 2, 2008, Pages 280-285

  Wang, Jianbo ^a,b   Day, Ryan ^a,b   Dong, Yiyu ^a,b   Weintraub, Steven J ^a,b   Michel, Loren ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN; PROTEIN TROP 2; TROP 2 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL STRAIN 3T3; COLON CANCER; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; ANTIBODIES; ANTIGENS, NEOPLASM; CELL ADHESION; CELL ADHESION MOLECULES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENE THERAPY; HCT116 CELLS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; ONCOGENES; RNA INTERFERENCE; TRANSFECTION; UP-REGULATION;

EID: 39749154101     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-07-2003     Document Type: Article

References (20)